Ten Years of EWAS

Adv Sci (Weinh). 2021 Oct;8(20):e2100727. doi: 10.1002/advs.202100727. Epub 2021 Aug 11.

Abstract

Epigenome-wide association study (EWAS) has been applied to analyze DNA methylation variation in complex diseases for a decade, and epigenome as a research target has gradually become a hot topic of current studies. The DNA methylation microarrays, next-generation, and third-generation sequencing technologies have prepared a high-quality platform for EWAS. Here, the progress of EWAS research is reviewed, its contributions to clinical applications, and mainly describe the achievements of four typical diseases. Finally, the challenges encountered by EWAS and make bold predictions for its future development are presented.

Keywords: DNA methylation; epigenetics; epigenome-wide association study (EWAS).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • CpG Islands / genetics
  • DNA Methylation / genetics*
  • Epigenome / genetics*
  • Genetic Diseases, Inborn / genetics*
  • Genetic Diseases, Inborn / pathology
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study
  • Humans
  • Sequence Analysis